ASCO 2014: Dr. Sharman on single agent obinituzumab

Hi friends,

More information on single agent obinituzumab AKA GA101 AKA Gazyva and CLL from ASCO 2014 on my blog: bkoffman.blogspot.com

I am posting all the audio interviews. The future looks bright. I have been working hard on a plan to build what needed to fill the yet unmet needs of the CLL community.

More soon.

Stay strong. We are all in this together.

Brian

bkoffman.blogspot.com

oldestnewest

You may also like...